Impedimed Ltd IPDQF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.00 / $0.01
- Shares Outstanding
- 3.66B
- Market Cap
- $8.15M
- Volume/Avg
- 19,916 / 102,399
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.86
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 73
- Website
- https://www.impedimed.com
Valuation
|
Metric
|
IPDQF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.09 |
Price/Sales | 0.86 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IPDQF
|
|---|---|
Quick Ratio | 3.10 |
Current Ratio | 3.81 |
Interest Coverage | −4.86 |
Quick Ratio
IPDQF
Profitability
|
Metric
|
IPDQF
|
|---|---|
Return on Assets (Normalized) | −63.37% |
Return on Equity (Normalized) | −183.04% |
Return on Invested Capital (Normalized) | −70.42% |
Return on Assets
IPDQF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>tQ%!&c | LOCK|hF@F | $183B | |||
| Medtronic PLC
MDT
| LOCK|L!mkCw | LOCK|y&Wh^ | $118B | |||
| Stryker Corp
SYK
| LOCK|>>K$ts! | LOCK|vrc | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|YTgt?m^ | LOCK|p&h@ | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Ln>s!^T> | LOCK|$?<Y | $50B | |||
| DexCom Inc
DXCM
| LOCK|<VlD#kb | LOCK|m$#ct | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|@%?%f! | LOCK|pGr | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>y | LOCK|^Qh | $25B | |||
| Steris PLC
STE
| LOCK|pyYT<F | LOCK|<<B$< | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|#<$<vj# | LOCK|$! | $18B |
United States